HYUGA PRIMARY CARE Co.,Ltd.

7133.T
Medical Care Facilities
2026/09/25 17:58 Updated
Market Cap: $60.7M (¥9.6B)
Stock Price: $8.52 (¥1,341)
Exchange Rate: 1 USD = ¥157.48

Notice of Revision of the End-of-Term Dividend for the Period (Reference: Notice on Implementation of MBO and Recommendation for Bid)

Under the condition of a take-private bid, the end-of-period dividend for the March 2027 period is revised to 0 yen. For the second quarter-end and the current period, 0 yen; prior year was 20 yen. The public tender offer of new share subscription warrants is a prerequisite and influences the policy. The annual dividend policy is shifted toward internal capital reserves.

Importance:
Page Updated: September 25, 2026
IR Disclosure Date: September 25, 2026

Key Figures

  • Dividend per share, Second Quarter End: 0 yen 00 sen
  • Dividend per share, End of Period: 0 yen 00 sen
  • Total Dividend: 0 yen 00 sen
  • Previous Term Actual: 20 yen 00 sen

AI要約

Revision of Dividend Policy

At today's Board of Directors meeting, based on taking the company's shares private by the purchaser, it was resolved not to pay the end-of-period dividend for the fiscal year ending March 2027. Consequently, the dividend forecast for the period has been revised. Background factors include the tender offer conditions and a review of internal reserves, with future shareholder returns subject to reconsideration.

Premise and Impact of the Tender Offer

The Board resolution was made on the premise that the tender offeror will succeed in this public tender offer and, after completing subsequent procedures, take the company's shares private. The dividend policy depends on whether the tender offer succeeds and on options for shareholder returns. The revision this time appears to prioritize financial and capital policy alignment if the tender offer is realized.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

HYUGA PRIMARY CARE Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →